These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2721988)

  • 1. Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles).
    Diepold R; Kreuter J; Himber J; Gurny R; Lee VH; Robinson JR; Saettone MF; Schnaudigel OE
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):188-93. PubMed ID: 2721988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system.
    Zimmer A; Mutschler E; Lambrecht G; Mayer D; Kreuter J
    Pharm Res; 1994 Oct; 11(10):1435-42. PubMed ID: 7855048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Saettone MF
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):1-7. PubMed ID: 10048342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
    Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
    Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
    Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
    Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
    Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
    Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flux of topical pilocarpine to the human aqueous.
    Krohn DL
    Trans Am Ophthalmol Soc; 1978; 76():502-27. PubMed ID: 754381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative intraocular levels of pilocarpine achieved with drops and repository preparations.
    Ellis PP; Riegel MA
    J Ocul Pharmacol; 1987; 3(2):121-8. PubMed ID: 3503909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pupillary, refractive, and hypotensive effects of Ocusert-40 and pilocarpine eyedrops in the treatment of chronic simple glaucoma.
    Smith SE; Smith SA; Friedmann AI; Chaston JM
    Br J Ophthalmol; 1979 Apr; 63(4):228-32. PubMed ID: 435437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiglaucoma ophthalmic agents with prolonged action based on macromolecular excipients. 2. In vivo studies].
    Pergande G; Keipert S; Klatt A
    Pharmazie; 1990 Jul; 45(8):587-91. PubMed ID: 2080204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of a new timolol/pilocarpine formulation.
    Bucolo C; Spadaro A; Mangiafico S
    Ophthalmic Res; 1998; 30(2):101-6. PubMed ID: 9523288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative distribution of pilocarpine in ocular tissues of the rabbit during administration by eyedrop or by membrane-controlled delivery systems.
    Sendelbeck L; Moore D; Urquhart J
    Am J Ophthalmol; 1975 Aug; 80(2):274-83. PubMed ID: 1155567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilocarpine concentrations in aqueous humor following single drop application. I. Effect of soft contact lenses.
    Ellis PP; Matsumura M; Rendi MA
    Curr Eye Res; 1985 Oct; 4(10):1041-7. PubMed ID: 4064728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems.
    Place VA; Fisher M; Herbst S; Gordon L; Merrill R
    Am J Ophthalmol; 1975 Oct; 80(4):706-12. PubMed ID: 1101690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine.
    Camber O; Edman P
    Curr Eye Res; 1989 Jun; 8(6):563-7. PubMed ID: 2743795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ocusert pilocarpine on anterior chamber depth, visual acuity and intraocular pressure in man.
    Drance SM; Mitchell DW; Schulzer M
    Can J Ophthalmol; 1977 Jan; 12(1):24-8. PubMed ID: 849537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of a new topical pilocarpine formulation.
    Bucolo C; Mangiafico P
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):567-73. PubMed ID: 10609779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.